(Q44394910)

English

Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment

scientific article published in April 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

Simultaneous occurrence of a t(9;22) (Ph) with a t(2;11) in a patient with CML and emergence of a new clone with the t(2;11) alone after imatinib mesylate treatment (English)

1 reference

Europe PubMed Central

2 December 2017

1 reference

based on heuristic

inferred from title

Brigitte Royer-Pokora

1

object named as

Royer-Pokora B

1 reference

Europe PubMed Central

2 December 2017

author name string

Hildebrandt B

2

1 reference

Europe PubMed Central

2 December 2017

Redmann A

3

1 reference

Europe PubMed Central

2 December 2017

Herold C

4

1 reference

Europe PubMed Central

2 December 2017

Kronenwett R

5

1 reference

Europe PubMed Central

2 December 2017

Haas R

6

1 reference

Europe PubMed Central

2 December 2017

Drechsler M

7

1 reference

Europe PubMed Central

2 December 2017

Wieland C

8

1 reference

Europe PubMed Central

2 December 2017

publication date

1 April 2003

1 reference

Europe PubMed Central

2 December 2017

1 reference

Europe PubMed Central

2 December 2017

17

1 reference

Europe PubMed Central

2 December 2017

807-810

1 reference

Europe PubMed Central

2 December 2017

4

1 reference

Europe PubMed Central

2 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402877

0 references

The biology of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402877

21 January 2018

Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402877

21 January 2018

Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402877

21 January 2018

Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402877

21 January 2018

Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402877

21 January 2018

Confirming evidence for the clonal development and stem cell origin of Philadelphia chromosome-negative chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402877

7 January 2021

based on heuristic

inferred from DOI database lookup

MLL is involved in a t(2;11)(p21;q23) in a patient with acute myeloblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402877

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.LEU.2402877

1 reference

Europe PubMed Central

2 December 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44394910&oldid=2020958688"